Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
63
days
Age‐Stratified Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndromes: A Comprehensive Review
AuthorsNing Wu; Meng Lv; Xiao‐Dong Mo; Yu‐Qian Sun; Yi‐Fei Cheng; Lan‐Ping Xu; Xiao‐Hui Zhang; Xiao‐Jun Huang; Yu Wang
Affiliations1. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University People's Hospital Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Peking University Beijing China; 2. Peking‐Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University Beijing China; 3. State Key Laboratory of Natural and Biomimetic Drugs Peking University Beijing China
164
days
The Germline SH2B3 rs111340708 Splicing Variant Drives Intron Retention and Protein Instability by Impacting Clinical Outcomes in Core Binding Factor AML
AuthorsMarta Rachele Stefanucci; Livia Leuzzi; Linda Montavoci; Davide Paolo Bernasconi; Luca Cimaschi; Alessandra Trojani; Anna Caretti; Lorenzo Del Castello; Roberto Cairoli; Alessandro Beghini
Affiliations1. Department of Health Sciences University of Milano Milano Italy; 2. Department of Hematology and Oncology ASST Grande Ospedale Metropolitano Niguarda Milano Italy; 3. UOC of Hematology ASST Fatebenefratelli Sacco Milano Italy; 4. Bicocca Bioinformatics Biostatistics and Bioimaging Centre University of Milano‐Bicocca Milano Italy
273
days
Epidemiology, Presenting Features and Treatment Outcomes of Patients With Chronic Lymphocytic Leukemia (CLL) in Tanzania
AuthorsSaida S. Saleh; Ahlam Nasser; Mwashungi Ally; Clara Chamba; Flora Ndobho; Magdalena Lyimo; Anna Schuh; William Frank Mawalla
Affiliations1. Department of Hematology and Blood Transfusion Muhimbili University of Health and Allied Sciences Dar es Salaam Tanzania; 2. Department of Hematology and Blood Transfusion Muhimbili National Hospital Dar es Salaam Tanzania; 3. Department of Oncology University of Oxford Oxford UK
307
days
Comparison of Thiotepa, Busulfan, and Cyclophosphamide Versus Busulfan and Thiotepa Conditioning Regimens in Autologous Stem Cell Transplantation for Primary CNS Lymphoma: A Multicenter Retrospective Analysis
AuthorsEun‐Jeong Jeong; Sang Eun Yoon; Sang‐A Kim; Ji Yun Lee; Seok Jin Kim; Soo‐Mee Bang; Won Seog Kim; Jeong‐Ok Lee
Affiliations1. Department of Internal Medicine Division of Hematology and Oncology Gyeongsang National University Hospital Gyeongsang National University College of Medicine Jinju South Korea; 2. Department of Medicine Division of Hematology‐Oncology Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Korea; 3. Department of Internal Medicine Seoul National University Bundang Hospital Seoul National University College of Medicine Seongnam South Korea
310
days
Dissecting Bone Marrow Fibrosis in Philadelphia‐Negative Myeloproliferative Neoplasms: Multiple Roads Lead to Rome
AuthorsMariagiovanna Ballato; Vincenzo Fiorentino; Gabriele Ricciardi; Pietro Tralongo; Emanuela Germanà; Alessandro Allegra; Fabio Stagno; Guido Fadda; Maurizio Martini
Affiliations1. Department of Biomedical, Dental, Morphological and Functional Imaging Sciences University of Messina Messina Italy; 2. Department of Human Pathology of Adult and Developmental Age “Gaetano Barresi” University of Messina Messina Italy
63
days
Metabolic Tumor Area: A Clinically Practical Prognostic Marker for Improved Risk Stratification in IPI Non‐High‐Risk DLBCL
AuthorsSilu Cui; Qi Jiang; Faquan Ji; Panpan Luan; Yuxiao Hu; Yu Zhang
Affiliations1. Jiangsu Province Hospital of Chinese Medicine Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing China; 2. Department of PET/CT Center Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University Nanjing China
72
days
Epigenetic Rewiring and Context‐Dependent Therapeutic Vulnerabilities in Myeloproliferative Neoplasms
AuthorsAmr Ali Mohamed Abdelgawwad El‐Sehrawy; Mutaz Jamal Al‐khreisat; Aziz Kubaev; Adilbek Rajapov; Sajida Hussein Ismael; Bahjat Alhasso; Irwanjot Kaur; Neeraj Bainsal
Affiliations1. Internal Medicine, Diabetes, Endocrinology and Metabolism Mansoura University Mansoura Egypt; 2. Faculty of Allied Medical Sciences Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan; 3. Department of Maxillofacial Surgery Samarkand State Medical University Samarkand Uzbekistan; 4. Department of Clinical Sciences Ma'mun University Urgench Uzbekistan; 5. College of Pharmacy, Department of Pharmaceutical Sciences AL‐Turath University Baghdad Iraq; 6. College of Pharmacy Alnoor University Nineveh Iraq; 7. Centre for Research Impact and Outcome Chitkara University Rajpura India; 8. Department of Chemistry & Biochemistry Sharda School of Engineering & Sciences Sharda University Greater Noida India; 9. University Institute of Pharma Sciences Chandigarh University Mohali India
217
days
Circulating Tumor DNA and Immune Response Markers for Improved Treatment Outcome Prediction in Diffuse Large B‐Cell Lymphoma: A Scoping Review
AuthorsAilin McMahon; Elizabeth J. Ryan; Sarah Dillon; Ruth Clifford
Affiliations1. Department of Haematology University Hospital Limerick Limerick Ireland; 2. Limerick Digital Cancer Research Centre Health Research Institute (HRI) University of Limerick Limerick Ireland
144
days
Venetoclax in Combination With Chemo‐Immunotherapy in Richter Transformation: A Real‐Life Experience
AuthorsL. Ballotta; J. Olivieri; D. Facchinelli; I. Ferrarini; A. Visentin; R. Moia; M. Cavallari; V. Innao; E. Derenzini; P. M. Nierychlewska; A. Cuda; V. Gattei; M. Ballerini; E. Lucchini; M. Turoldo; M. C. Rossetti; F. Gaudio; F. Zaja
Affiliations1. UCO Ematologia ASUGI Azienda Sanitaria Universitaria Giuliano Isontina Ospedale Maggiore Trieste Trieste Italy; 2. Clinica di Ematologia Centro Trapianti e Terapie Cellulari Carlo Melzi ASUFC—Azienda Sanitaria Universitaria Friuli Centrale—Ospedale Civile “Santa Maria della Misericordia” Udine Udine Italy; 3. UOC Ematologia ULSS8 Ospedale San Bortolo di Vicenza Vicenza Italy; 4. Hematology Unit Section of Biomedicine of Innovation Department of Engineering for Innovation Medicine University of Verona Verona Italy; 5. U.O. di Ematologia Dipartimento di Medicina Università di Padova Padova Italy; 6. Divisione di Ematologia Dipartimento di Medicina Traslazionale Università del Piemonte Orientale Novara Italy; 7. U.O. Ematologia ULSS3 Serenissima Ospedale dell'Angelo Venezia Italy; 8. U.O.C Ematologia A.R.N.A.S. Garibaldi Catania Italy; 9. Divisione di Oncoematologia Istituto Europeo Oncologico (IEO) Milano Italy; 10. SC Direzione Medica Cattinara e Maggiore ASUGI Azienda Sanitaria Universitaria Giuliano Isontina Trieste Italy; 11. Centro di Riferimento Oncologico (CRO) IRCCS SOC Onco‐Ematologia Clinico Sperimentale Aviano Italy; 12. Clinical Research Coordinator UCO Ematologia ASUGI Azienda Sanitaria Universitaria Giuliano Isontina Ospedale Maggiore Trieste Trieste Italy; 13. Department of Medicine and Surgery LUM University “Giuseppe Degennaro” Casamassima Italy; 14. Hematology Unit ‐ Ecclesiastical Entity Regional General Hospital “F. Miulli” Acquaviva delle Fonti Italy; 15. Dipartimento Universitario Clinico di Scienze Mediche Chirurgiche e della Salute Università di Trieste Trieste Italy
108
days
Langerhans Cell Histiocytosis in Adults: A Canadian Multicenter Case Series
AuthorsStephanie Quon; Yaswanta Gummadi; Ibrahim Elsharawi; Jessica Dobson; Mariam Goubran; Ryan J. Stubbins; Eli L. Diamond; Luke Y. C. Chen
Affiliations1. Faculty of Medicine University of British Columbia Vancouver British Columbia Canada; 2. Department of Medicine Dalhousie University Halifax Nova Scotia Canada; 3. Department of Pathology Dalhousie University Halifax Nova Scotia Canada; 4. Department of Diagnostic Radiology Dalhousie University Halifax Nova Scotia Canada; 5. Division of Hematology University of British Columbia Vancouver British Columbia Canada; 6. Coastal Rare Inflammatory Diseases Program Halifax Nova Scotia Canada; 7. Department of Neurology Memorial Sloan Kettering Cancer Center New York New York USA; 8. Division of Hematology Dalhousie University Halifax Nova Scotia Canada
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days